Tien Liang Biotech Co Ltd Reports Earnings Results for the Third Quarter Ended September 30, 2018
November 12, 2018 at 01:38 pm EST
Share
Tien Liang Biotech Co Ltd. announced earnings results for the third quarter ended September 30, 2018. For the third quarter, the company announced sales was TWD 121.039 million compared to TWD 97.111 million a year ago. Operating loss was TWD 21.535 million compared to TWD 82.429 million a year ago. Net loss was TWD 36.019 million compared to net income of TWD 67.087 million a year ago. Basic loss per share was TWD 0.79 compared to basic earnings per share of TWD 1.47 a year ago. For the nine months, sales was TWD 386.676 million compared to TWD 384.104 million a year ago. Operating loss was TWD 44.744 million compared to TWD 191.963 million a year ago. Net loss was TWD 63.601 million compared to TWD 200.902 million a year ago. Basic loss per share was TWD 1.39 compared to TWD 4.39 a year ago.
Tien Liang BioTech Co., Ltd. is a Taiwan-based company principally engaged in the manufacture, wholesale and retail of health food products. The Company is also involved in the import, wholesale and retail of western medicines, as well as the manufacture and sales of traditional Chinese medicines. The Company also provides active pharmaceutical ingredients (APIs), biopharmaceuticals and others. The Company distributes its products in domestic market.